{
    "root": "6cb3fa6e-1116-427e-adbe-43bfcd968c11",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Dicyclomine Hydrochloride",
    "value": "20250319",
    "ingredients": [
        {
            "name": "DICYCLOMINE HYDROCHLORIDE",
            "code": "CQ903KQA31",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4515"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "CALCIUM SULFATE, UNSPECIFIED FORM",
            "code": "WAT0DDB505",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31346"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "indications": {
        "text": "dicyclomine hydrochloride capsules indicated treatment patients functional bowel/irritable bowel syndrome .",
        "doid_entities": [
            {
                "text": "syndrome (DOID:225)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_225"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "must adjusted individual patient needs .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "dicyclomine hydrochloride capsules , usp , 10 mg 10 mg white capsules `` twi t201 `` ink white body `` 10 mg `` ink , capsule contains white white powder blend , supplied bottles 100 1000 capsules . store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . ndc 68788-8525-2 20 capsules per bottle ndc 68788-8525-3 30 capsules per bottle ndc 68788-8525-6 60 capsules per bottle ndc 68788-8525-1 100 capsules per bottle",
    "adverseReactions": "dicyclomine hydrochloride contraindicated infants less 6 months age [ ( 8.4 ) ] , nursing mothers [ ( 8.3 ) ] , patients : \u2022unstable cardiovascular status acute hemorrhage \u2022myasthenia gravis [ ( 5.4 ) ] \u2022glaucoma [ ( 6.3 ) ( 7.1 ) ] \u2022obstructive uropathy [ ( 5.8 ) ] \u2022obstructive disease gastrointestinal tract [ ( 5.5 ) ] \u2022severe ulcerative colitis [ ( 5.7 ) ] \u2022reflux esophagitis",
    "indications_original": "Dicyclomine hydrochloride capsules are indicated for the treatment of patients with functional bowel/irritable bowel syndrome.",
    "contraindications_original": "Dosage must be adjusted to individual patient needs.",
    "warningsAndPrecautions_original": "Dicyclomine Hydrochloride Capsules, USP, 10 mg\n                  \n                  10 mg\u00a0white capsules with \"TWi T201\" ink and white body with\"10 mg\" ink, and the capsule contains white to off white powder blend, supplied in bottles of 100 and 1000 capsules. Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [See USP Controlled Room Temperature].\u00a0\n                  \n                     \n                        \u00a0NDC 68788-8525-2\t 20 capsules per bottle\n                  \n                  NDC 68788-8525-3\t 30 capsules per bottle\n                  NDC 68788-8525-6\t 60 capsules per bottle\n                  NDC 68788-8525-1\t 100 capsules per bottle",
    "adverseReactions_original": "Dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see Use in Specific Populations (8.4)], nursing mothers [see Use in Specific Populations (8.3)], and in patients with:\n                  \n                     \n                        \u2022unstable cardiovascular status in acute hemorrhage\n                     \n                        \u2022myasthenia gravis [see Warnings and Precautions (5.4)]\n                     \n                     \n                        \u2022glaucoma [see Adverse Reactions (6.3) and Drug Interactions (7.1)]\n                     \n                     \n                        \u2022obstructive uropathy [see Warnings and Precautions (5.8)]\n                     \n                     \n                        \u2022obstructive disease of the gastrointestinal tract [see Warnings and Precautions (5.5)]\n                     \n                     \n                        \u2022severe ulcerative colitis [see Warnings and Precautions (5.7)]\n                     \n                     \n                        \u2022reflux esophagitis",
    "drug": [
        {
            "name": "Dicyclomine Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4515"
        }
    ]
}